Recently, Hwang et al. demonstrated that TAMs stimulate VEGF-A and VEGF-C in tumor cells, thereby promoting angiogenesis and lymphangiogenesis at tumor site (Hwang et al., 2020). Here, VEGFC is linked to neoplasm.